Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 202
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04039724 | Pharmacokinetics of HCP1305 and Co-administration of HCP0605, HGP0816 in Healthy Male Volunteers | ||
| NCT03228277 | Olmutinib Trial in T790M (+) NSCLC Patients Detected by Liquid Biopsy Using BALF Extracellular Vesicular DNA | ||
| NCT01894399 | Study to Evaluate a Pharmacokinetic of HM61713 in Healthy Male Subjects | ||
| NCT03332836 | Multiple Ascending Dose Study of HM12460A in Type 2 Diabetes Mellitus | ||
| NCT01775579 | Evaluating a Pharmacokinetic Drug Interaction Between Metformin Hydrochloride and Rosuvastatin Calcium | ||
| NCT02545829 | Evaluating the Bioequivalence of HIP1302, HGP1406 | ||
| NCT02941796 | Pharmacokinetics and Safety of HCP1105 and Co-administration of HGP0918, HGP0816 in Healthy Male Volunteers | ||
| NCT04322266 | A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination and Co-Administration of HGP0904, HGP0608 and HCP1306 Tablets in Healthy Male Subjects. | ||
| NCT03371849 | PK and Safety Study of HCP1102, HGP0813 and HGP1408 | ||
| NCT05548387 | A Study to Evaluate the Pharmacokinetics and Safety Between HCP2202 and Co-administration of Each Component in Healthy Volunteers | ||
| NCT02712411 | Pharmacokinetics and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 in Healthy Male Volunteers | ||
| NCT05450575 | An Observational Study to Evaluate Effectiveness and Safety of Amosartan Q Tablet | ||
| NCT02715401 | PK and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 Under Fed Condition in Healthy Male Volunteers | ||
| NCT04732416 | HM15136 (Efpegerglucagon) Treatment for 8 Weeks in Subjects Aged ≥2 Years With Congenital Hyperinsulinism (CHI) | ||
| NCT02390882 | A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HGP0412 and HIP1402 in Patients With BPH | ||
| NCT00973115 | Efficacy and Safety of Morning Versus Evening Intake of Simvast Controlled Release (CR) Tablet in Patients With Hyperlipidemia | ||
| NCT06346184 | A Study to Evaluate the Pharmacokinetics and Safety Between HCP2303 and Co-administration of Each Component in Healthy Volunteers | ||
| NCT05723549 | A Study to Evaluate the PK, Safety and Tolerability of HCP1803. | ||
| NCT04946903 | A Study to Evaluate the Pharmacokinetics and Safety Between HCP1902 and Co-administration of RLD2007, RLD2008 | ||
| NCT01093742 | A Study of HM10560A in Healthy Male Subject | ||
| NCT03330314 | Molar Potency Study of HM12460A in Healthy Subjects | ||
| NCT06438172 | A Study to Evaluate Efficacy and Safety of HCP1803 Compared to RLD2001-1 in Patients with Essential Hypertension | ||
| NCT02302443 | A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12470 | ||
| NCT01688193 | Study to Evaluate and Compare Safety and Pharmacokinetics of the HCP1004 and VIMOVO 500/20mg in Healthy Korean Male | ||
| NCT02473900 | Evaluating the Bioequivalence of HIP1403, HGP0919 | ||
| NCT01013064 | A Study of HM10760A (Long-acting Erythropoietin (EPO)) in Healthy Korean Subjects | ||
| NCT04768686 | FLX475 Combined With Pembrolizumab in Patients With Advanced or Metastatic Gastric Cancer | ||
| NCT05450601 | A Study to Evaluate the Efficacy and Safety of HCP2102 in Essential Hypertension Patients | ||
| NCT01724814 | A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12460A | ||
| NCT05481307 | A Study to Evaluate Pharmacokinetic/Pharmacodynamic Drug-drug Interaction and Safety/Tolerability Between RLD2202 and RLD2203 | ||
| NCT06724016 | Dose Escalation and Expansion Study of HM16390 Alone or With Pembrolizumab in Advanced or Metastatic Solid Tumors | ||
| NCT02011633 | Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 500mg and Rosuvastatin 10mg | ||
| NCT00979563 | Clinical Trial to Evaluate Safety and Tolerability of OratecanTM in Patients With Advanced Solid Malignancies | ||
| NCT02294539 | Comparison of Effects Between Amlodipine and Hydrochlorothiazide in Combination With Losartan on 24-hr Central Blood Pressure in Hypertensive Patients | ||
| NCT01197001 | A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and Losartan | ||
| NCT01872182 | Efficacy and Safety Study of ALS-L1023 in Patients With Abdominal Obesity of Metabolic Syndrome | ||
| NCT04654702 | Observational Study to Evaluate Therapeutic Effectiveness and Safety of Monterizine Cap. | ||
| NCT01555398 | Clinical Trial to Evaluate the Effect of Food on the Pharmacokinetic Characteristics of HIP0901 Capsule | ||
| NCT02552667 | Efficacy and Safety of HCP1102 Capsule | ||
| NCT02587988 | Trial to Evaluate the Efficacy and Safety of HCP1302 | ||
| NCT01455571 | Phase I Study to Determine the Maximum Tolerated Dose and to Assess the Safety and Pharmacokinetic Profile of HM781-36B in Patients With Advanced Solid Tumors | ||
| NCT02941731 | Evaluating the Bioequivalence of HIP1403 and HGP0919 Suspensions | ||
| NCT05555238 | An Observational Study to Evaluate the Treatment of Newvast® Tab(Atorvastatin) in Korean Patients With Dyslipidemia | ||
| NCT02444819 | Phase II Trial to Evaluate the Efficacy and Safety of HM61713 as the 1st-line NSCLC Anticancer Therapy | ||
| NCT04074551 | A Phase 3 Study to Compare the Efficacy and Safety of Co-administered HGP0608, HGP0904 and HCP1306 Versus HCP1701 in Patients With Hypertension and Dyslipidemia | ||
| NCT04324905 | Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of HIP1802 to HGP1705 in Healthy Volunteers | ||
| NCT03882112 | Food-effect on PK and PD of Single Oral Dose of HIP1601 in Healthy Male Subjects | ||
| NCT01463982 | Phase I of OratecanTM in Combination With Capecitabine in Patients With Advanced Solid Malignancies | ||
| NCT05845489 | Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- CloPidogREl for Primary preVENTION (HOST-PREVENTION) | ||
| NCT02387554 | Pharmacokinetic Interaction Between HGP0904, HGP0608 and HGP1405 |
